This is especially important given that patients with fibromyalgia have difficulty attending treatment sessions in person.
A number of shortcomings are associated with systematic reviews and meta-analyses of postoperative care.
Egalet announced the launch of Arymo ER extended-release tablets for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment.
A new clinical practice guideline regarding the use of opioids for chronic pain has been released by the VA and DoD.
A training program on opioid prescribing for general practice registrars was developed to improve adherence to guidelines on opioid prescribing for chronic noncancer pain.
Standardized and clinically meaningful outcome measures in clinical trials in chronic pain may enhance efforts to develop effective treatments for chronic pain patients.
An individual's pain experience depends on a complex interaction between various biological, environmental, psychological, and societal factors.
The Empower Veterans Program was created by the Atlanta Veterans Administration Medical Center to improve quality of life through active self-care in veterans with chronic pain.
Dr Stacey sought to highlight how the healthcare community reacted to and coped in the aftermath of the closing of the Seattle Pain Center, by coming together as a team and mobilizing state resources.
Comparative chart of narcotic analgesics including formulations, strengths, and dosing intervals.
Reward feedback responses in the brain may be predictive of chronic pain complaints later on.
Most patients (85%) who discontinued long-term opioid use did so because of a clinician's, rather than a patient decision.
Viewing photographs can decrease pain intensity in patients with chronic pain.
Clinical Pain Advisor interviewed Penney Cowan, founder and chief executive officer of the ACPA to learn more about the importance of the ACPA's resource for HCPs.
Pain interference was found to mediate the relationship between pain and depression in children with chronic pain.
A targeted form of CBT is effective in treating chronic pain and substance use disorder in veterans with hepatitis C virus infection.
Compare the abuse deterrent mechanism, special risk groups, contraindications, and warnings/precautions for FDA approved opioids.
Opioids prescribed for pain following a motor vehicle collision do not reduce the likelihood of developing persistent pain.
Rapid increases in prescription opioid dose may lead to higher rates of new-onset depression.
A new evidence-based classification system for chronic sickle cell disease pain was recently published.
Spinal cord stimulation was found to help decrease or stabilize opioid use in patients with chronic pain.
Pharmaceutical companies are working to develop non-opioid drugs for chronic and postoperative pain.
For patients with chronic pain receiving opioids, provider satisfaction is not associated with functional outcomes.
Many analgesics and analgesic combinations for chronic pain have shown temporary and permanent otological effects, including hearing loss.
The Polyanalgesic Consensus Conference updated guidelines regarding the treatment of pain via intrathecal therapy.
Yoga only led to moderate improvements compared with exercise or no exercise interventions in patients with low back pain.
It may be that some veterans would benefit from a revised pain management plan with an emphasis on patient-centered care.
Many patients experience pain months after nephrectomy. Continuous surgical site analgesia may offer the best long-term pain control.
The motivation for pain relief is higher in patients compared with healthy individuals.
Veterans with back and jaw pain, severe headaches or migraine, and neck pain had significantly more severe pain compared with non-veterans with the same conditions.
Clinical Pain Advisor Articles
- Transcranial Random Noise Stimulation Effective on Multiple Fibromyalgia-Associated Symptoms
- Comparing Dry Needling, Cortisone for Greater Trochanteric Pain Syndrome
- Vestibular Rehabilitation an Effective Treatment for Vestibular Migraine
- Secondary Hyperalgesia Mediated by Nociceptive and Other Sensory Pathways
- Naloxone: Policies and Access